{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:27:48Z","timestamp":1759991268445},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1991,6,1]],"date-time":"1991-06-01T00:00:00Z","timestamp":675734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1991,6]]},"DOI":"10.1007\/bf01726447","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T07:36:09Z","timestamp":1118561769000},"page":"395-400","source":"Crossref","is-referenced-by-count":3,"title":["Low-dose zidovudine in combination with either acyclovir or lymphoblastoid interferon-alpha in asymptomatic HIV-infected patients: A pilot study"],"prefix":"10.1007","volume":"19","author":[{"given":"R.","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. W.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Siegenthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"L\u00fcthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Spacey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01726447_CR1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","volume":"220","author":"F. Barr\u00e9-Sinoussi","year":"1983","unstructured":"Barr\u00e9-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauget, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W., Montagnier, L. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220 (1983) 868\u2013871.","journal-title":"Science"},{"key":"BF01726447_CR2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1126\/science.6200936","volume":"224","author":"R. C. Gallo","year":"1984","unstructured":"Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., White, G., Foster, P., Markham, P. D. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224 (1984) 500\u2013503.","journal-title":"Science"},{"key":"BF01726447_CR3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.6200935","volume":"224","author":"M. Popovic","year":"1984","unstructured":"Popovic, M., Sarngadharan, M. G., Read, E., Gallo, R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224 (1984) 497\u2013500.","journal-title":"Science"},{"key":"BF01726447_CR4","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1073\/pnas.82.20.7096","volume":"82","author":"H. Mitsuya","year":"1985","unstructured":"Mitsuya, H., Weinhold, K. J., Furman, P. A., St. Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W., Broder, S. 3\u2032-azido-3\u2032-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III\/lymphadenopathy-associated virusin vitro. Proc. Natl. Acad. Sci. USA 82 (1985) 7096\u20137100.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF01726447_CR5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198707233170401","volume":"317","author":"M. A. Fischl","year":"1987","unstructured":"Fischl, M. A., Richmann, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., Jackson, G. G., Durack, D. T., Phil, D., King, D., andthe AZT Collaborative Working Group The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N. Engl. J. Med. 317 (1987) 185\u2013191.","journal-title":"N. Engl. J. Med."},{"key":"BF01726447_CR6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1056\/NEJM198707233170402","volume":"317","author":"D. D. Richman","year":"1987","unstructured":"Richman, D. D., Fischl, M. A., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Hirsch, M. S., Jackson, G. G., Durack, D. T., Nusinoff-Lehrman, S., andthe AZT Collaborative Working Group The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double- blind, placebo-controlled trial. N. Engl. J. Med. 317 (1987) 192\u2013197.","journal-title":"N. Engl. J. Med."},{"key":"BF01726447_CR7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(86)92808-4","volume":"i","author":"R. Yarchoan","year":"1986","unstructured":"Yarchoan, R., Klecker, R. W., Weinhod, K. J., Markham, P. D., Lyerly, H. K., Durack, D. T., Gelmann, E., Lehrmann, S. N., Blum, R. M., Barry, D. W., Shearer, G. M., Fischl, M. A., Mitsuya, H., Gallo, R. C., Collins, J. M., Bolognesi, D. P., Myers, C. E., Broder, S. Administration of 3\u2032-azido-3\u2032deoxythymidine, an inhibitor of HTLV-III\/LAV replication, to patients with AIDS or AIDS-related complex. Lancet i (1986) 575\u2013580.","journal-title":"Lancet"},{"key":"BF01726447_CR8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJM199004053221401","volume":"322","author":"P. A. Volberding","year":"1990","unstructured":"Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., Murphy, R. L., Hardy, W. D., Soeiro, R., Fischl, M. A., Bartlett, J. G., Merigan, T. C., Hyslop, N. E., Richmann, D. D., Valentine, F. T., Corey, L., andThe AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N. Engl. J. Med. 322 (1990) 941\u2013949.","journal-title":"N. Engl. J. Med."},{"key":"BF01726447_CR9","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.2467383","volume":"243","author":"B. A. Larder","year":"1989","unstructured":"Larder, B. A., Darby, G., Richman, D. D. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243 (1989) 1731\u20131734.","journal-title":"Science"},{"key":"BF01726447_CR10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/AAC.31.2.168","volume":"31","author":"K. L. Hartshorn","year":"1987","unstructured":"Hartshorn, K. L., Vogt, M. W., Chou, T. C., Blumberg, R. S., Byington, R., Schooley, R. T. Hirsch, M. S. Synergistic inhibition of human immunodeficiency virusin vitro by azidothymidine and recombinant alpha-interferon. Antimicrob. Agents Chemother. 31 (1987) 168\u2013172.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01726447_CR11","first-page":"303","volume-title":"AIDS: modern concepts and therapeutic challenges","author":"H. Mitsuya","year":"1987","unstructured":"Mitsuya, H., Matsukura, M., Broder, S. Rapidin vitro systems for assessing activity of agents against HTLV-III\/LAV. In:Broder, S. (ed.): AIDS: modern concepts and therapeutic challenges. Marcel Dekker, New York 1987, pp. 303\u2013333."},{"key":"BF01726447_CR12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/325773a0","volume":"325","author":"H. Mitsuya","year":"1987","unstructured":"Mitsuya, H., Broder, S. Strategies for antiviral therapy in AIDS. Nature 325 (1987) 773\u2013778.","journal-title":"Nature"},{"key":"BF01726447_CR13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/infdis\/158.2.378","volume":"158","author":"M. W. Vogt","year":"1988","unstructured":"Vogt, M. W., Durno, A. G., Chou, T. C., Colemann, L. A., Paradis, T. J., Schooley, R. T., Kaplan, J. C., Hirsch, M. S. Synergistic interaction of 2\u2032,3\u2032-dideoxycytidine and recombinant interferonalpha-A on replication of human immunodeficiency virus type 1. J. Infect. Dis. 158 (1988) 378\u2013385.","journal-title":"J. Infect. Dis."},{"key":"BF01726447_CR14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/infdis\/159.5.837","volume":"159","author":"V. A. Johnson","year":"1989","unstructured":"Johnson, V. A., Barlow, M. A., Chou, T. C., Fisher, R. A., Walker, B. D., Hirsch, M. S., Schooley, R. T. Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replicationin vitro by recombinant soluble CD4 and 3\u2032-azido-3\u2032-deoxythymidine. J. Infect. Dis. 159 (1989) 837\u2013844.","journal-title":"J. Infect. Dis."},{"key":"BF01726447_CR15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1128\/AAC.33.1.53","volume":"33","author":"V. A. Johnson","year":"1989","unstructured":"Johnson, V. A., Walker, B. D., Barlow, M. A., Paradis, T. J., Chou, T. C., Hirsch, M. S. Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replicationin vitro by castanospermine and 3\u2032-azido-3\u2032-deoxythymidine. Antimicrob. Agents Chemother. 33 (1989) 53\u201357.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01726447_CR16","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(87)92862-5","volume":"i","author":"W. M. Mitchell","year":"1987","unstructured":"Mitchell, W. M., Montefiori, D. C., Robinson Jr., W. E., Strayer, D. R., Carter, W. A. Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azido-thymidine) required forin vitro inhibition of human immunodeficiency virus. Lancet i (1987) 890\u2013892.","journal-title":"Lancet"},{"key":"BF01726447_CR17","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.168.3.1111","volume":"168","author":"C. F. Perno","year":"1988","unstructured":"Perno, C. F., Yarchoan, R., Cooney, D. A., Hartmann, N. R., Gartner, S., Popovic, M., Hao, Z., Gerrard, T. L., Wilson, Y. A., Johns, D. G. Inhibition of human immunodeficiency virus (HIV-1\/HTLV-IIBa-L) replication in fresh and cultured human peripheral blood monocytes\/macrophages by azidothymidine and related 2\u2032,3\u2032-dideoxynucleosides. J. Exp. Med. 168 (1988) 1111\u20131125.","journal-title":"J. Exp. Med."},{"key":"BF01726447_CR18","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(87)90681-7","volume":"i","author":"R. Ueno","year":"1987","unstructured":"Ueno, R., Kuno, S. Dextrane sulphate, a potent anti-HIV agentin vitro having synergism with zidovudine. Lancet i (1987) 1379.","journal-title":"Lancet"},{"key":"BF01726447_CR19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/infdis\/158.3.615","volume":"158","author":"F. Wolf De","year":"1988","unstructured":"De Wolf, F., Lange, J. M. A., Houweling, J. T., Coutinho, R. A., Schellekens, P. T., Van der Noordaa, J., Goudsmit, J. Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J. Infect. Dis. 158 (1988) 615\u2013622.","journal-title":"J. Infect. Dis."},{"key":"BF01726447_CR20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0002-9343(89)90380-X","volume":"86","author":"H. W. Murray","year":"1989","unstructured":"Murray, H. W., Godbold, J. H., Jurica, K. B., Roberts, R. B. Progression to AIDS in patients with lymphadenopathy or AIDS-related complex: reappraisal of risk and predictive factors. JAMA 86 (1989) 533\u2013538.","journal-title":"JAMA"},{"key":"BF01726447_CR21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1182\/blood.V70.2.575.575","volume":"70","author":"Y. Z. Cao","year":"1987","unstructured":"Cao, Y. Z., Valentine, F., Hojvat, S., Allain, J. P., Rubinstein, P., Mirabile, M., Czelusniak, S., Leuther, M., Baker, L., Friedman-Kien, A. E. Detection of HIV antigen and specific antibodies to HIV core and envelope proteins in sera of patients with HIV infection. Blood 70 (1987) 575\u2013578.","journal-title":"Blood"},{"key":"BF01726447_CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7326\/0003-4819-108-2-175","volume":"108","author":"G. G. Jackson","year":"1988","unstructured":"Jackson, G. G., Paul, D. A., Falk, L. A., Rubenis, M., Despotes, J. C., Mack, D., Knigge, M., Emeson, E. E. Human immunodeficiency virus (HIV) antigenemia (p24) and the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT). Ann. Intern. Med. 108 (1988) 175\u2013180.","journal-title":"Ann. Intern. Med."},{"key":"BF01726447_CR23","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1056\/NEJM198912143212402","volume":"321","author":"R. W. Coombs","year":"1989","unstructured":"Coombs, R. W., Collier, A. C., Allain, J. P., Nikora, B., Leuther, M., Gjerset, G. F., Corey, L. Plasma viremia in human immuno-deficiency virus infection. N. Engl. J. Med. 321 (1989) 1626\u20131631.","journal-title":"N. Engl. J. Med."},{"key":"BF01726447_CR24","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM198912143212401","volume":"321","author":"D. D. Ho","year":"1989","unstructured":"Ho, D. D., Moudgil, T., Alam, M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321 (1989) 1621\u20131625.","journal-title":"N. Engl. J. Med."},{"key":"BF01726447_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/325067a0","volume":"325","author":"J. D. Mosca","year":"1987","unstructured":"Mosca, J. D., Bednarik, P. D., Rai, N. B. K., Rosen, C. A., Sodroski, J. G., Haseltine, W. A., Pitha, P. M. Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature 325 (1987) 67\u201370.","journal-title":"Nature"},{"key":"BF01726447_CR26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-111-4-293","volume":"111","author":"A. Bonetti","year":"1989","unstructured":"Bonetti, A., Weber, R., Vogt, M. W., Wunderli, W., Siegenthaler, W., L\u00fcthy, R. Coinfection with human immunodeficiency virus type 1 (HIV-1) and cytomegalovirus in two intravenous drug users. Ann. Intern. Med. 111 (1989) 293\u2013296.","journal-title":"Ann. Intern. Med."},{"key":"BF01726447_CR27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.3277274","volume":"239","author":"A. S. Fauci","year":"1988","unstructured":"Fauci, A. S. The human immunodeficiency virus: infectivity and mechanism of pathogenesis. Science 239 (1988) 617\u2013622.","journal-title":"Science"},{"key":"BF01726447_CR28","unstructured":"Cooper, D. A., Aiuti, F., Vilde, J. L. and a European-Australian Collaborative Group: The efficacy and safety of zidovudine + acyclovir administered four times daily in the treatment of patients with AIDS-related complex: a double-blind, placebo-controlled trial. (submitted)."},{"issue":"Suppl. I","key":"BF01726447_CR29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0163-4453(89)80084-2","volume":"18","author":"A. P. Fiddian","year":"1989","unstructured":"Fiddian, A. P. anda Collaborative European\/Australian Study Group Preliminary report of a multicentre study of zidovudine plus or minus acyclovir in patients with acquired immune deficiency syndrome or acquired immune deficiency syndrome-related complex. J. Infect. 18 (Suppl. I) (1989) 79\u201380.","journal-title":"J. Infect."},{"key":"BF01726447_CR30","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0002-9343(89)80394-8","volume":"87","author":"H. Hollander","year":"1989","unstructured":"Hollander, H., Lifson, A. R., Maha, M., Blum, M. R., Rutherford, G. W., Nusinoff-Lehrman, S. Phase I study of low-dose zidovudine and acyclovir in asymptomatic human immunodeficiency virus seropositive individuals. JAMA 87 (1989) 628\u2013632.","journal-title":"JAMA"},{"key":"BF01726447_CR31","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-108-4-534","volume":"108","author":"A. Surbone","year":"1988","unstructured":"Surbone, A., Yarchoan, R., McAtee, N., Blum, M. R., Maha, M., Allain, J. P., Thomas, R. V., Mitsuya, H., Lehrmann, S. N., Leuther, M., Pluda, J. M., Jacobsen, F. K., Kessler, H. A., Myers, C. E., Broder, S. Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3\u2032-azido-2\u2032,3\u2032-dideoxythymidine (azidothymidine or zidovudine) and acyclovir: a pilot study. Ann. Intern. Med. 108 (1988) 534\u2013540.","journal-title":"Ann. Intern. Med."},{"key":"BF01726447_CR32","first-page":"602","volume":"i","author":"D. D. Ho","year":"1985","unstructured":"Ho, D. D., Hartshorn, K. L., Rota, T. R., Andrews, C. A., Kaplan, J. C., Schooley, R. T., Hirsch, M. S. Recombinant human interferon alpha-A suppresses HTLV-III replicationin vitro. Lancet i (1985) 602\u2013604.","journal-title":"Lancet"},{"key":"BF01726447_CR33","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/1097-0142(19860415)57:8+<1709::AID-CNCR2820571315>3.0.CO;2-F","volume":"57","author":"G. J. Jones","year":"1986","unstructured":"Jones, G. J., Itri, L. M. Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients. Cancer 57 (1986) 1709\u20131715.","journal-title":"Cancer"},{"key":"BF01726447_CR34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(89)91166-5","volume":"i","author":"B. R. Edlin","year":"1989","unstructured":"Edlin, B. R., Falk, L., Weinstein, R. A., Bitran, J. Interferon-alpha plus zidovudine in HIV infection. Lancet i (1989) 156.","journal-title":"Lancet"},{"key":"BF01726447_CR35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-111-4-280","volume":"111","author":"J. A. Kovacs","year":"1989","unstructured":"Kovacs, J. A., Deyton, L., Davey, R., Falloon, J., Zunick, K., Lee, D., Metcalf, J. A., Bigley, J. W., Sawyer, L. A., Zoon, K. C., Masur, H., Fauci, A. S., Lane, H. C. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann. Int. Med. 111 (1989) 280\u2013287.","journal-title":"Ann. Int. Med."},{"key":"BF01726447_CR36","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/infdis\/163.4.710","volume":"163","author":"O. Berglund","year":"1991","unstructured":"Berglund, O., Engman, K., Ehrnst, A., Andersson, J., Lidman, K., Akerlund, B., S\u00f6nnerborg, A., Strannegard, O. Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine. J. Infect. Dis. 163 (1991) 710\u2013715.","journal-title":"J. Infect. Dis."},{"key":"BF01726447_CR37","first-page":"1","volume":"4","author":"M. A. Fischl","year":"1991","unstructured":"Fischl, M. A., Uttamchandani, R. B., Resnick, L. A phase I study of recombinant human interferon alfa-2a or human lymphoblastoid interferon alfa-n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. J. Acquired Immune Defic. Syndrome 4 (1991) 1\u201310.","journal-title":"J. Acquired Immune Defic. Syndrome"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01726447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01726447\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01726447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T17:37:34Z","timestamp":1586281054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01726447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1991,6]]}},"alternative-id":["BF01726447"],"URL":"https:\/\/doi.org\/10.1007\/bf01726447","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,6]]}}}